1-6 of 6
Keywords: Plasminogen activator
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Cerebrovasc Dis (2009) 27 (2): 160–166.
Published Online: 18 December 2008
... were treated with intravenous recombinant tissue-type plasminogen activator between April 2006 and April 2008. Data were extracted from a prospectively collected database. Baseline demographic data, and clinical, laboratory and imaging findings were analyzed. Outcome was assessed using the modified...
Journal Articles
Cerebrovasc Dis (2007) 24 (1): 1–10.
Published Online: 22 May 2007
... of the twelve studies. Symptom severity was an independent risk factor in three of the studies and advanced age, increased time to treatment, high systolic blood pressure, low platelets, history of congestive heart failure and low plasminogen activator inhibitor levels were found to be independent risk factors...
Journal Articles
Cerebrovasc Dis (2007) 23 (4): 304–308.
Published Online: 29 December 2006
... with acute ischemic stroke (AIS) and assessed the safety and efficacy of recombinant tissue plasminogen activator (rtPA) administration in a community-based setting. Methods: A retrospective review of patients >80 years (n = 341) admitted to a community stroke center with AIS were compared...
Journal Articles
Journal Articles
Cerebrovasc Dis (1997) 7 (6): 318–323.
Published Online: 31 October 1997
... of symptomatic hemorrhagic complication after combined therapy does not seem to be markedly greater than after thrombolysis alone. Plasminogen activator Tissue type Heparin Cerebral infarction Hemorrhage Cerebrovascular Diseases M. Grond J. Rudolf M. Neveling C. Stenzei W.-D. Heiss Max-Planck-Instilul...
Journal Articles